Picture of Apellis Pharmaceuticals logo

APLS — Apellis Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Apellis Pharmaceuticals Q1 Basic EPS USD -0.74

May 07 (Reuters) - Apellis Pharmaceuticals Q1 product revenue USD 149.9 million.

Q1 operating expenses USD 250.125 million

Q1 net income USD -92.225 million

Q1 operating income USD -83.328 million

Recent news on Apellis Pharmaceuticals

See all news